← Back to front page
United States · Exchanges & live quotes · Nasdaq

Johnson & Johnson To Acquire Ollin Biosciences In $2.2 Bln Deal

Published by Nasdaq · United States 36 min ago

Detailed summary

(RTTNews) - Healthcare company Johnson & Johnson (JNJ) announced on Monday that it has agreed to acquire clinical-stage biopharmaceutical company Ollin Biosciences for $2.2…

Read the full article on Nasdaq Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.nasdaq.com)

Also worth reading